business

business

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline - Novartis

Novartis Announces Strategic Transaction to Strengthen Neuroscience Franchise In a significant move, Novartis has made an announcement regarding a strategic transaction that is expected to strengthen its neuroscience franchise. The company has identified three late-stage programs that target genetic neuromuscular diseases, and this development is being shared with the public

By Lau Chi Fung

business

If I Could Buy Only 1 "Magnificent Seven" Stock Over the Next 10 Years, This Would Be It (Hint: Not Nvidia) - Yahoo Finance

The Rise and Fall of The Magnificent Seven Stocks: A Summary The Magnificent Seven stocks, which include NVIDIA (NVDA), Advanced Micro Devices (AMD), Intel Corporation (INTC), Texas Instruments Incorporated (TXN), Micron Technology (MU), Dell Technologies (DELL), andQualcomm Incorporated (QCOM), have been a dominant force in the technology sector since the

By Lau Chi Fung